期刊
EXPERT REVIEW OF CARDIOVASCULAR THERAPY
卷 10, 期 9, 页码 1185-1194出版社
TAYLOR & FRANCIS INC
DOI: 10.1586/ERC.12.102
关键词
allogeneic; autologous; cardiac tissue derived; cardiosphere-derived cells; cardiospheres; cellular therapy; heart disease; intracoronary; infusion; intramuscular injection
资金
- ALLSTAR Phase 2
- NIH
- California Institute for Regenerative Medicine
- Cedars-Sinai Board of Governors Heart Stem Cell Center
Heart disease is a major cause of morbidity and mortality. Cellular therapies hold significant promise for patients with heart disease. Heart-derived progenitor cells are capable of repairing a diseased heart through modulation of growth factor milieu and temporary engraftment leading to endogenous repair. The proof-of-concept CADUCEUS clinical trial using cardiosphere-derived cells has shown evidence of therapeutic cardiac tissue regeneration. Future clinical trials are now being planned to generate additional safety and efficacy data in the hopes of building toward an approved cellular therapy for heart disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据